Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARA Cure FA

Author

Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Executive Director

Display #

Title	Created Date	Category
Pharmacological therapeutics in Friedreich Ataxia: The present state	Friday, July 21, 2017	Funded Research
Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model	Friday, July 21, 2017	Funded Research
Cal for Abstracts - 10th Annual Friedreich’s Ataxia Symposium	Thursday, July 20, 2017	Scientific News
AFAF and FARA invite proposals for research projects that advance drug discovery, development of novel biomarkers or improve clinical outcomes in Friedreich’s ataxia patients	Sunday, July 16, 2017	Funded Research
Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients	Friday, July 14, 2017	Scientific News
How does performance of the Friedreich Ataxia Functional Composite compare to rating scales?	Wednesday, July 12, 2017	Funded Research
Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency	Wednesday, June 7, 2017	Funded Research
Reata Pharmaceuticals, Inc. Announces Positive Data From Part One of Moxie Trial of Omaveloxolone for Friedreich’s Ataxia	Thursday, June 1, 2017	Supported Research
Cerebral compensation during motor function in Friedreich ataxia: The IMAGE-FRDA study	Wednesday, May 31, 2017	Scientific News
Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy	Friday, May 26, 2017	Funded Research

Page 1 of 70

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End